Published in AIDS on March 01, 1991
Strongyloides stercoralis in the Immunocompromised Population. Clin Microbiol Rev (2004) 5.41
Disseminated strongyloidiasis: a retrospective study of clinical course and outcome. Eur J Clin Microbiol Infect Dis (2006) 1.50
Tropical respiratory medicine. 1. Pulmonary infections in the tropics: impact of HIV infection. Thorax (1994) 1.41
Eosinophilic pneumonias. Clin Microbiol Rev (2012) 1.20
Strongyloidiasis: a conundrum for gastroenterologists. Gut (1994) 1.02
Neuroparasitic infections: nematodes. Semin Neurol (2005) 0.98
Central nervous system Strongyloides stercoralis in acquired immunodeficiency syndrome: a report of two cases and review of the literature. Acta Neuropathol (1993) 0.89
Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) in Strongyloides stercoralis Hyperinfection. J Glob Infect Dis (2014) 0.87
First-glance diagnosis of Strongyloides stercoralis autoinfection by stool microscopy. J Clin Microbiol (1999) 0.83
Parasitic pneumonia and lung involvement. Biomed Res Int (2014) 0.81
Parasitic disease screening among HIV patients from endemic countries in a Toronto clinic. Can J Infect Dis Med Microbiol (2012) 0.79
Central Nervous System Strongyloidiasis and Cryptococcosis in an HIV-Infected Patient Starting Antiretroviral Therapy. Case Rep Med (2012) 0.79
Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet (1995) 21.03
Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet (1978) 10.25
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet (2009) 7.96
In vitro synthesis and secretion of lysozyme by mononuclear phagocytes. J Exp Med (1974) 7.43
Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories. J Clin Microbiol (1996) 4.81
Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS. BMJ (1991) 4.67
Indicators of socioeconomic status for adolescents: the WHO Health Behaviour in School-aged Children Survey. Health Educ Res (1997) 3.66
AIDS--an immunologic reevaluation. N Engl J Med (1984) 3.53
"A bit more truthful": the validity of adolescent sexual behaviour data collected in rural northern Tanzania using five methods. Sex Transm Infect (2004) 3.37
Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania. Lancet (1998) 3.22
Genotypic identification of pathogenic Mycobacterium species by using a nonradioactive oligonucleotide probe. J Clin Microbiol (1991) 2.90
HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS. Am J Pathol (1986) 2.77
Is antenatal syphilis screening still cost effective in sub-Saharan Africa. Sex Transm Infect (2003) 2.77
Microarray analysis of developing Arabidopsis seeds. Plant Physiol (2000) 2.62
Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. J Infect Dis (2002) 2.61
Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology (1990) 2.58
HTLV-III: should testing ever be routine? Br Med J (Clin Res Ed) (1986) 2.51
An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol (1996) 2.49
Studies of cellular immunity in male homosexuals in London. Lancet (1983) 2.41
A new set of Arabidopsis expressed sequence tags from developing seeds. The metabolic pathway from carbohydrates to seed oil. Plant Physiol (2000) 2.39
Value of immune-complex assays in diagnosis and management. Lancet (1978) 2.39
Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania. J Infect Dis (1999) 2.37
Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis. Lancet (1987) 2.34
Safety and activity of saquinavir in HIV infection. Lancet (1995) 2.32
Risk assessment and other screening options for gonorrhoea and chlamydial infections in women attending rural Tanzanian antenatal clinics. Bull World Health Organ (1995) 2.29
Relapses in Wegener's granulomatosis: the role of infection. Br Med J (1980) 2.29
Remission of myasthenia gravis following plasma-exchange. Lancet (1976) 2.25
Immunocytochemical detection of T and B cell populations in routine blood smears. Lancet (1984) 2.17
Baseline survey of sexually transmitted infections in a cohort of female bar workers in Mbeya Region, Tanzania. Sex Transm Infect (2003) 2.14
An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital. J Hosp Infect (1998) 2.10
Wegener's granulomatosis: observations on 18 patients with severe renal disease. Q J Med (1983) 2.07
The frequency of the fragile X chromosome among schoolchildren in Coventry. J Med Genet (1986) 2.06
Sexual behaviour patterns and other risk factors for HIV infection in rural Tanzania: a case-control study. AIDS (1997) 2.05
Three-year prospective study of HTLV-III/LAV infection in homosexual men. Lancet (1986) 2.04
Translating global health research aims into action: the example of the ALPHA network. Trop Med Int Health (2010) 1.99
Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in VACUTAINER CPT, VACUTAINER PPT, and standard VACUTAINER tubes. J Clin Microbiol (1995) 1.98
Male circumcision and susceptibility to HIV infection among men in Tanzania. AIDS (1997) 1.97
Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens (1998) 1.96
Mycobacterial infection in patients infected with the human immunodeficiency virus. Thorax (1990) 1.95
Evidence for a cerebral effect of the hepatitis C virus. Lancet (2001) 1.90
Population incidence and segregation ratios in the Martin-Bell syndrome. Am J Med Genet (1986) 1.86
Malaria prevalence is inversely related to vector density in The Gambia, West Africa. Trans R Soc Trop Med Hyg (1995) 1.82
A community study of severe mental retardation in the West Midlands and the importance of the fragile X chromosome in its aetiology. J Med Genet (1985) 1.80
The neuropil of the glomeruli of the olfactory bulb. J Cell Sci (1971) 1.79
Factors affecting seropositivity to human T cell lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDS. Genitourin Med (1986) 1.77
Oxygen-15 brain scanning for detection of cerebral involvement in systemic lupus erythematosus. Lancet (1978) 1.75
Sexual and reproductive health among primary and secondary school pupils in Mwanza, Tanzania: need for intervention. AIDS Care (1998) 1.75
Ineffectiveness of AL721 in HIV disease. Lancet (1990) 1.73
Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study. J Hepatol (1996) 1.73
Plasma-exchange and immunosuppression in the treatment of fulminating immune-complex crescentic nephritis. Lancet (1977) 1.71
Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange. Neurology (1978) 1.71
Role of fibreoptic bronchoscopy in management of pneumonia in acquired immune deficiency syndrome. Br Med J (Clin Res Ed) (1985) 1.68
Cardiovascular risk evaluation and antiretroviral therapy effects in an HIV cohort: implications for clinical management: the CREATE 1 study. Int J Clin Pract (2010) 1.68
Clinical testing of olfaction reassessed. Brain (1977) 1.68
An immunohistological approach to persistent lymphadenopathy and its relevance to AIDS. Clin Exp Immunol (1985) 1.64
Asymptomatic gonorrhoea and chlamydial infection in rural Tanzanian men. BMJ (1996) 1.63
The acquired immune deficiency syndrome. Clin Exp Immunol (1984) 1.62
Rationale and design of the MEMA kwa Vijana adolescent sexual and reproductive health intervention in Mwanza Region, Tanzania. AIDS Care (2006) 1.62
Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy. Q J Med (1990) 1.61
A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants. J Infect Dis (1995) 1.61
A community trial of the impact of improved sexually transmitted disease treatment on the HIV epidemic in rural Tanzania: 2. Baseline survey results. AIDS (1995) 1.60
Absolute copy number and relative change in determinations of human immunodeficiency virus type 1 RNA in plasma: effect of an external standard on kit comparisons. J Clin Microbiol (1998) 1.60
Helicobacter pylori and HIV infection. Lancet (1990) 1.59
Changing disease patterns in AIDS. BMJ (1991) 1.59
Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J (1999) 1.57
A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, west Africa. 4. Perceptions of the causes of malaria and of its treatment and prevention in the study area. Trans R Soc Trop Med Hyg (1993) 1.56
Nucleoside incorporation into strain L cells: inhibition by pleuropneumonia-like organisms. Science (1965) 1.56
Lung function abnormalities in patients infected with the human immunodeficiency virus with and without overt pneumonitis. Thorax (1988) 1.56
Prostitutes and their clients: a Gambian survey. Soc Sci Med (1992) 1.55
The neuron types of the glomerular layer of the olfactory bulb. J Cell Sci (1971) 1.52
Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease. Gut (1990) 1.51
Low mortality risk but high loss to follow-up among patients in the Tanzanian national HIV care and treatment programme. Trop Med Int Health (2012) 1.51
Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation. Health Technol Assess (2006) 1.50
Managing HIV disease after Delta. BMJ (1996) 1.49
Tolerability and side-effects of post-exposure prophylaxis for HIV infection. Lancet (2000) 1.49
Pulmonary function in human immunodeficiency virus infection. A prospective 18-month study of serial lung function in 474 patients. Am Rev Respir Dis (1992) 1.49
Definition of chronic fatigue syndrome (CFS) Br J Psychiatry (1991) 1.47
Jejunal enteropathy associated with human immunodeficiency virus infection: quantitative histology. J Clin Pathol (1989) 1.47
Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study. Gastroenterology (1997) 1.47
The epidemiology of HIV infection in a rural area of Guinea-Bissau. AIDS (1993) 1.45
Two strategies for correcting refractive errors in school students in Tanzania: randomised comparison, with implications for screening programmes. Br J Ophthalmol (2008) 1.44
Welfare reform: advocacy and intervention in the health care setting. Public Health Rep (2000) 1.44
Kaposi's sarcoma in HIV infection treated with vincristine and bleomycin. AIDS (1992) 1.43
Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Res Hum Retroviruses (1995) 1.42
Identity cards for patients infected with HIV? Br Med J (Clin Res Ed) (1987) 1.42
Cytomegalovirus infection in gastrointestinal tracts of patients infected with HIV-1 or AIDS. J Clin Pathol (1989) 1.41
Diagnosis and management of long-standing benign oral ulceration. Laryngoscope (1980) 1.41
Association of different allelic forms of group specific component with susceptibility to and clinical manifestation of human immunodeficiency virus infection. Lancet (1987) 1.41
HIV and AIDS. Nature (1990) 1.39
Who owns AIDS? Br J Hosp Med (1997) 1.39
AIDS and HTLV-III/LAV infection: consequences for obstetrics and perinatal medicine. Br J Obstet Gynaecol (1985) 1.39
Formulations of didanosine (ddI) and salt overload. Lancet (1992) 1.38
The acquired immunodeficiency syndrome--what next? Med J Aust (1989) 1.38
Plasma exchange. Br J Hosp Med (1978) 1.36
HIV testing: changing trends at a clinic for sexually transmitted diseases in London. Br Med J (Clin Res Ed) (1987) 1.36